Paper4875305
The biology of graft-versus-host reactions.
Billingham RE. Harvey Lect, 1966. Cited by 342 papers, by iCite.
Cite this record
ConductScience Library. The biology of graft-versus-host reactions. Papers, record 4875305. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4875305
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Infant, Newborn, Diseases | Major topic |
| Transplantation Immunology | Major topic |
| Age Factors | |
| Animals | |
| Chickens | |
| Humans | |
| Immune Sera | |
| Immunity | |
| Infant, Newborn | |
| Lymphoid Tissue | |
| Mammals | |
| Mice | |
| Parabiosis | |
| Radiation Effects | |
| Rats | |
| Salmonella Infections | |
| Salmonella typhimurium | |
| Splenomegaly | |
| Thymectomy | |
| Transplantation, Homologous | |
| Vaccines | |
| Virus Diseases |
Source PubMed
Cited by140
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 342 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41655162 | Designing immune reconstitution to prevent graft-versus-host disease: a novel therapeutic paradigm beyond T cell suppression. | Int J Hematol | 2026 | https://conductscience.org/library/papers/41655162 | PubMed |
| 40117296 | Cellular therapies for the prevention and treatment of acute graft-versus-host disease. | Stem Cells | 2025 | https://conductscience.org/library/papers/40117296 | PubMed |
| 39916964 | Case report: Toxic epidermal necrolysis as a unique presentation of acute graft versus host disease in a pediatric patient. | Front Immunol | 2024 | https://conductscience.org/library/papers/39916964 | PubMed |
| 39328417 | Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/39328417 | PubMed |
| 39233318 | Population pharmacokinetic modeling of vedolizumab for graft-versus-host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant. | Pharmacol Res Perspect | 2024 | https://conductscience.org/library/papers/39233318 | PubMed |
| 39035005 | A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39035005 | PubMed |
| 38558826 | Research advances on short-chain fatty acids in gastrointestinal acute graft-versus-host disease. | Ther Adv Hematol | 2024 | https://conductscience.org/library/papers/38558826 | PubMed |
| 37761936 | The Role of MicroRNA in Graft-Versus-Host-Disease: A Review. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37761936 | PubMed |
| 37291149 | Acute graft-versus-host disease. | Nat Rev Dis Primers | 2023 | https://conductscience.org/library/papers/37291149 | PubMed |
| 37247105 | Acute Graft-versus-Host Disease: An Update on New Treatment Options. | Drugs | 2023 | https://conductscience.org/library/papers/37247105 | PubMed |
| 36544776 | Milestones in acute GVHD pathophysiology. | Front Immunol | 2022 | https://conductscience.org/library/papers/36544776 | PubMed |
| 36187719 | Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation. | World J Biol Chem | 2022 | https://conductscience.org/library/papers/36187719 | PubMed |
| 36166494 | Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36166494 | PubMed |
| 36039647 | C-C chemokine receptor 5 and acute graft-versus-host disease. | Immun Inflamm Dis | 2022 | https://conductscience.org/library/papers/36039647 | PubMed |
| 35814515 | Acute Graft Versus Host Disease Following Liver Transplantation: Case Report With Review of Current Literature. | J Clin Exp Hepatol | 2022 | https://conductscience.org/library/papers/35814515 | PubMed |
| 35782373 | Graft versus host disease after liver transplantation: A case report. | Hepatol Forum | 2022 | https://conductscience.org/library/papers/35782373 | PubMed |
| 35679154 | Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35679154 | PubMed |
| 35657433 | STR typing of skin swabs from individuals after an allogeneic hematopoietic stem cell transplantation. | Int J Legal Med | 2023 | https://conductscience.org/library/papers/35657433 | PubMed |
| 35386853 | Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19? | Drug Des Devel Ther | 2022 | https://conductscience.org/library/papers/35386853 | PubMed |
| 34786412 | Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: Report of six cases. | World J Clin Cases | 2021 | https://conductscience.org/library/papers/34786412 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4875305
GET https://conductscience.org/api/papers/v1/4875305/cited_by?page=2